Videos

Edward B. Garon, MD, discusses remaining questions with fam-trastuzumab deruxtecan-nxki in the field of lung cancer.

Dr. Garon on the Role of Trastuzumab Deruxtecan in Lung Cancer

Edward B. Garon, MD, discusses unique challenges of the coronavirus disease 2019 in lung cancer.  



Dr. Garon on Unique Challenges of COVID-19 in Lung Cancer 

Edward B. Garon, MD, discusses the expanding treatment landscape in lung cancer.

Dr. Garon on the Expanding Treatment Landscape in Lung Cancer

Grace Cherry, RN, ​MSN, NP, discusses ​recent advances in melanoma. 

Recent Advances in Melanoma 

Articles

The combination of pepinemab and avelumab was found to be well tolerated and demonstrated initial signals of antitumor activity in patients with advanced stage, non–small cell lung cancer.

Pepinemab/Avelumab Combo Shows Early Tolerability and Antitumor Activity in Advanced NSCLC

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyze gene-expression patterns in the most aggressive prostate cancer grade group&mdash;known as Gleason grade group 5&mdash;and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.

UCLA Jonsson Comprehensive Cancer Center

Latest from UCLA Jonsson Comprehensive Cancer Center

New content coming soon, please check back later.